New Brunswick, New Jersey, United States In 1979 was created Johnson & Johnson Development Corporation, which is appeared as VC. The fund was located in North America if to be more exact in United States. Johnson & Johnson Development Corporation appeared to be a CVC structure as part of the corporation. The main department of described VC is located in the New Brunswick.
Opposing the other organizations, this Johnson & Johnson Development Corporation works on 0 percentage points more the average amount of lead investments. The fund is generally included in 7-12 deals every year. Deals in the range of 10 - 50 millions dollars are the general things for fund. Speaking about the real fund results, this VC is 2 percentage points less often commits exit comparing to other organizations. The important activity for fund was in 2009. Despite it in 2019 the fund had an activity. The average startup value when the investment from Johnson & Johnson Development Corporation is 10-50 millions dollars. The increased amount of exits for fund were in 2014.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Johnson & Johnson Development Corporation, startups are often financed by InterWest Partners, Prism Venture Management, Polaris Partners. The meaningful sponsors for the fund in investment in the same round are Quaker BioVentures, InterWest Partners, Delphi Ventures. In the next rounds fund is usually obtained by Domain Associates, SR One, Medtronic.
This organization was formed by John L. Cassis. The overall number of key employees were 1.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. We can highlight the next thriving fund investment areas, such as Medical Device, Biotechnology. Among the various public portfolio startups of the fund, we may underline GRAIL, NovoCure, 23andMe
Related Funds
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Osteal Therapeutics | $23M | 21 Sep 2023 | San Clemente, California, United States | ||
Osteal Therapeutics | $30M | 08 Mar 2022 | San Clemente, California, United States | ||
| $1B | 01 Mar 2017 | California, United States | |||
Fusion Pharmaceuticals | $25M | 23 Feb 2017 | Hamilton, Ontario, Canada | ||
Cala Health | $18M | 16 Feb 2016 | California, United States | ||
PhaseBio Pharmaceuticals | $40M | 12 Mar 2015 | Pennsylvania, United States | ||
Willow | $15M | 21 Jan 2015 | Mountain View, California, United States | ||
Padlock Therapeutics | $23M | 18 Dec 2014 | Cambridge, Massachusetts, United States | ||
La Lumiere | $20M | 11 Nov 2014 | Cleveland, Ohio, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Osteal Therapeutics | $23M | 21 Sep 2023 | San Clemente, California, United States | ||
Osteal Therapeutics | $30M | 08 Mar 2022 | San Clemente, California, United States | ||
| $1B | 01 Mar 2017 | California, United States | |||
Fusion Pharmaceuticals | $25M | 23 Feb 2017 | Hamilton, Ontario, Canada | ||
Cala Health | $18M | 16 Feb 2016 | California, United States | ||
PhaseBio Pharmaceuticals | $40M | 12 Mar 2015 | Pennsylvania, United States | ||
Willow | $15M | 21 Jan 2015 | Mountain View, California, United States | ||
Padlock Therapeutics | $23M | 18 Dec 2014 | Cambridge, Massachusetts, United States | ||
La Lumiere | $20M | 11 Nov 2014 | Cleveland, Ohio, United States |
